Showing posts with label Gastroesophageal Reflux Disease (GERD) Devices Market. Show all posts
Showing posts with label Gastroesophageal Reflux Disease (GERD) Devices Market. Show all posts

Thursday, 27 February 2020

Gastroesophageal Reflux Disease (GERD) Devices Market set to Grow At 4% CAGR by 2028|FMI Report

Exceeding the revenue of US$ 1 billion in 2018, the global sales of gastroesophageal disease devices will witness a steady over 4% CAGR during 2018-2028. As indicated in a new intelligence outlook of Future Market Insights (FMI), esphagoscopes and gastroscopes will continue to account for most of the sales. Adoption of gastroesophageal reflux disease devices will remain maximum for diagnostic procedures, followed by fundoplication procedures.

More Patients Continue to Prefer GERD Devices over Lifestyle Modifications & PPIs

Besides the rapid expansion of geriatric population and elevating prevalence rate of obesity-driven gastroesophageal reflux diseases, FMI in a new study states that the frequent intake of asthma medications is also a strong impact factor associated with the growth of gastroesophageal reflux disease devices market.
Although industry experts recommend lifestyle modifications as the most suitable remedy for gastroesophageal diseases, the growing demand for surgeries for obesity will continue to drive sales of gastroesophageal disease devices in coming years.

Although industry experts recommend lifestyle modifications as the most suitable remedy for gastroesophageal diseases, the growing demand for surgeries for obesity will continue to drive sales of gastroesophageal disease devices in coming years.

The second line of treatment for gastroesophageal reflux disease includes proton pump inhibitors (PPI) therapy, which can reduce the usage of gastroesophageal reflux disease devices. Proton pump inhibitors are the drugs that regulate acid production within stomach, and thereby restrict gastroesophageal reflux.

However, the proven side effects and functional failure of proton pump inhibitors in the long run will continue to benefit the demand for surgical treatment of gastroesophageal reflux disease, favoring the overall sales of gastroesophageal reflux disease devices such as PH monitoring system and manometry system.

Diagnostic Centers & Private Clinics to Employ More GERD Devices

While a majority of adoption of gastroesophageal reflux disease devices prevails in hospitals, the constantly increasing number of establishments in the ambulatory surgical center and diagnostic center segments is likely to translate into a higher rate of adoption of gastroesophageal reflux disease devices within the latter two.
With the number of diagnostic centers and private practice clinics on the constant rise, it is more likely that the demand for gastroesophageal reflux disease devices will observe steady growth over the years to come. Towards the end of forecast period, global market value share of clinics and diagnostic centers will be more than 35%, as suggested by FMI’s analysis of the gastroesophageal reflux disease devices market.

Key GERD Device Manufacturers Eyeing New Product Launches

The report tracks some of the key companies operating in the Gastroesophageal Reflux Disease Devices market, such as Olympus Corporation, Pentax Medical, Medtronic Plc., Diversatek Inc. The report also tracks the key manufacturers operating in gastroesophageal reflux disease treatment devices, such as EndoGastric Solutions, Medigus Ltd., Torax Medical, Inc. and Mederi RF, Inc.

A majority of key manufacturers of gastroesophageal reflux disease devices are emphasizing new product launches. Innovation of new and advanced products is in turn shaping the growth of gastroesophageal reflux disease devices market.

According to the report findings,
  • Olympus Corporation and Pentax Medical hold the maximum company share in the gastroesophageal reflux disease devices market.
  • Olympus Corporation recently launched an advanced version of esophagoscope and gastroscope.
  • Plc. and Diversatek, Inc. are the key players of diagnostic devices for gastroesophageal reflux disease, contributing a significant share in overall gastroesophageal reflux disease devices market.
  • EsophyX Z is the new and advanced version of EsophyX gastroesophageal reflux disease device, used for the transoral incisionless fundoplication process.

 More from FMI’s Healthcare, Pharmaceuticals and Medical devices Market Intelligence:
About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s largest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

Tuesday, 4 June 2019

Gastroesophageal Reflux Disease (GERD) Devices Market Size, Share And Trends Analysis Report By Product, By Segment Forecasts 2018 - 2028 | Olympus Corporation, Pentax Medical

Gastroesophageal Reflux Disease (GERD) Devices Market - Key Research Findings
  1. Global gastroesophageal reflux disease devices market size in 2017 – Over US$ 970 Mn
  1. The gastroesophageal reflux disease devices market will observe just-over 4% CAGR over 2018-2028
  1. According to World Gastroenterology Organization,
  • There are reported differences in the prevalence of gastroesophageal reflux disease, ranging from 2.5% to 6.6% in Asia up to 13.8% to 25.8% in North America.
  1. North America will remain the largest regional markets for gastroesophageal reflux disease devices
  • Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disease in the US as the rate of obesity is very high.
  • The high rate of obesity in the US is one of the major factors contributing to the growth of gastroesophageal reflux disease devices market within North America.
  1. Asia Pacific holds high growth potential for gastroesophageal reflux disease devices market
  • Increasing healthcare awareness and increasing establishments of diagnostic centres and hospitals prominently fuel the growth of gastroesophageal reflux disease devices market within APAC.
  1. By product type, esophagoscopes and gastroscopes, hold the maximum market share in the gastroesophageal reflux disease devices market.
  1. The diagnostic devices as a segment of gastroesophageal reflux disease devices market covers esophageal manometry system and PH monitoring device.
  2. The treatment devices, which is another key segment of gastroesophageal reflux disease devices market, cover ultrasonic surgical endostapler, fundoplication gastroesophageal reflux disease devices, sphincter augmentation gastroesophageal reflux disease devices, and radiofrequency ablation gastroesophageal reflux disease devices.
    gastroesophageal reflux diseases devices market
Top 3 Factors Shaping Gastroesophageal Reflux Disease Devices Market
  • Increasing Prevalence of Abdominal Obesity Continues to Drive Demand for Gastroesophageal Reflux Disease Devices Market
The increasing prevalence of gastroesophageal reflux disease is correlated with the increasing prevalence of obesity in many countries and presence of other poor diet and lifestyle factors. This increases the demand of gastroesophageal reflux disease devices. The difference in the prevalence of gastroesophageal reflux does not depend on the gender, but males are expected to face a higher rate of complications, associated with the disease. The prevalence or gastroesophageal generally increases with age, particularly after age 40.
  • Increasing Geriatric Population Remains among Primary Boosters for Growth of Gastroesophageal Reflux Disease Devices Market
Esophagus malfunctioning in the geriatric population is associated with the disturbances associated with esophageal motility and a decreased production of saliva. Increasing geriatric population will thus remain an important factor driving the gastroesophageal reflux disease devices market. Some of the frequently consumed medications such as bisphosphonates, non-steroidal anti-inflammatory drugs (NSAIDs), and potassium tablets often affect the esophageal motility and the lower esophageal sphincter’s functionality, which in turn is responsible for demand growth of of gastroesophageal reflux disease devices.
  • Sedentary Lifestyle Shift Continues to Push Demand for Gastroesophageal Reflux Diseases Devices
Several environmental factors and the prominent lifestyle evolution to sedentary habits such as a high dietary fat intake, shorter dinner-to-bed time, and frequent smoking and alcohol consumption have been proven as the high risk factors associated with the prevalence of gastroesophageal reflux diseases. Lack of adequate physical activity, coupled with increasing body mass index and obesity, are likely to continue fueling the instances of gastroesophageal reflux diseases, thereby generating demand for GERD devices.
Gastroesophageal Reflux Disease Devices Market Structure Analysis
  • The global gastroesophageal reflux disease devices market represents a consolidated competition landscape, wherein Tier 1 companies hold more than 70% revenue share.
  • Top companies in the gastroesophageal reflux disease devices market include Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG., Medtronic Plc, and Fujifilm Holdings Corporation.
  • While most of the key players maintain strategic focus on the partnerships with other companies and also distribution expansion of various products in different geographies.
  • Leading players in gastroesophageal reflux disease devices market are also concentrating on technological innovation for the better treatment of gastroesophageal reflux diseases.

Sunday, 2 June 2019

Gastroesophageal Reflux Disease (GERD) Devices Market: Effect and Growth Factors Research and Projection 2018-2028

Gastroesophageal Reflux Disease (GERD) Devices Market - Key Research Findings
  1. Global gastroesophageal reflux disease devices market size in 2017 – Over US$ 970 Mn
  1. The gastroesophageal reflux disease devices market will observe just-over 4% CAGR over 2018-2028
  1. According to World Gastroenterology Organization,
  • There are reported differences in the prevalence of gastroesophageal reflux disease, ranging from 2.5% to 6.6% in Asia up to 13.8% to 25.8% in North America.
  1. North America will remain the largest regional markets for gastroesophageal reflux disease devices
  • Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disease in the US as the rate of obesity is very high.
  • The high rate of obesity in the US is one of the major factors contributing to the growth of gastroesophageal reflux disease devices market within North America.
  1. Asia Pacific holds high growth potential for gastroesophageal reflux disease devices market
  • Increasing healthcare awareness and increasing establishments of diagnostic centres and hospitals prominently fuel the growth of gastroesophageal reflux disease devices market within APAC.
  1. By product type, esophagoscopes and gastroscopes, hold the maximum market share in the gastroesophageal reflux disease devices market.
  1. The diagnostic devices as a segment of gastroesophageal reflux disease devices market covers esophageal manometry system and PH monitoring device.
  2. The treatment devices, which is another key segment of gastroesophageal reflux disease devices market, cover ultrasonic surgical endostapler, fundoplication gastroesophageal reflux disease devices, sphincter augmentation gastroesophageal reflux disease devices, and radiofrequency ablation gastroesophageal reflux disease devices.
  1.  gastroesophageal reflux diseases devices market
Top 3 Factors Shaping Gastroesophageal Reflux Disease Devices Market
  • Increasing Prevalence of Abdominal Obesity Continues to Drive Demand for Gastroesophageal Reflux Disease Devices Market
The increasing prevalence of gastroesophageal reflux disease is correlated with the increasing prevalence of obesity in many countries and presence of other poor diet and lifestyle factors. This increases the demand of gastroesophageal reflux disease devices. The difference in the prevalence of gastroesophageal reflux does not depend on the gender, but males are expected to face a higher rate of complications, associated with the disease. The prevalence or gastroesophageal generally increases with age, particularly after age 40.
  • Increasing Geriatric Population Remains among Primary Boosters for Growth of Gastroesophageal Reflux Disease Devices Market
Esophagus malfunctioning in the geriatric population is associated with the disturbances associated with esophageal motility and a decreased production of saliva. Increasing geriatric population will thus remain an important factor driving the gastroesophageal reflux disease devices market. Some of the frequently consumed medications such as bisphosphonates, non-steroidal anti-inflammatory drugs (NSAIDs), and potassium tablets often affect the esophageal motility and the lower esophageal sphincter’s functionality, which in turn is responsible for demand growth of of gastroesophageal reflux disease devices.
  • Sedentary Lifestyle Shift Continues to Push Demand for Gastroesophageal Reflux Diseases Devices
Several environmental factors and the prominent lifestyle evolution to sedentary habits such as a high dietary fat intake, shorter dinner-to-bed time, and frequent smoking and alcohol consumption have been proven as the high risk factors associated with the prevalence of gastroesophageal reflux diseases. Lack of adequate physical activity, coupled with increasing body mass index and obesity, are likely to continue fueling the instances of gastroesophageal reflux diseases, thereby generating demand for GERD devices.
Gastroesophageal Reflux Disease Devices Market Structure Analysis
  • The global gastroesophageal reflux disease devices market represents a consolidated competition landscape, wherein Tier 1 companies hold more than 70% revenue share.
  • Top companies in the gastroesophageal reflux disease devices market include Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG., Medtronic Plc, and Fujifilm Holdings Corporation.
  • While most of the key players maintain strategic focus on the partnerships with other companies and also distribution expansion of various products in different geographies.
  • Leading players in gastroesophageal reflux disease devices market are also concentrating on technological innovation for the better treatment of gastroesophageal reflux diseases.

Pillow Cases Market Current Industry Size and Future Prospective with Key Players, Drivers and Trends

  In an upcoming market research study, Future Market Insights (FMI) brings to fore both macro- and microeconomic factors that will shape th...